Assessing the Novel Myval Balloon-Expandable Valve with the Evolut Valve: A Propensity-Matched Study.
Jonathan HalimMaxim J P RooijakkersPeter den HeijerMilad El HaddadBen van den BrandenJeroen VosBas SchölzelMartijn MeuwissenMenno van GamerenSaloua El MessaoudiNiels van RoyenSander IJsselmuidenPublished in: Journal of clinical medicine (2023)
Safety and efficacy outcomes were comparable between the two valves, except for a higher PPI rate for the Evolut SE valve. Up to 1-year follow-up, clinical outcomes showed acceptable rates of stroke and cardiac death with both valves. Valve hemodynamics were excellent with a low rate of moderate-severe PVL in both groups.
Keyphrases
- aortic valve
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve replacement
- mitral valve
- transcatheter aortic valve replacement
- left ventricular
- ejection fraction
- atrial fibrillation
- heart failure
- coronary artery disease
- small molecule
- type diabetes
- blood brain barrier
- drug induced
- cerebral ischemia